DeLiver Pharma ApS Financials, key figures and credit report
Gross profit -20.5 kDKK FY 2025 -98.9% vs 2024
EBIT -31.9 kDKK FY 2025 -47% vs 2024
Net debt - 110.3 kDKK FY 2025 +14.1% vs 2024
Quick ratio 8.4 FY 2025 -3.3 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -21.88 | -17.95 | 118.66 | -10.30 | -20.49 |
| Total depreciation | - 125.03 | -11.38 | -11.38 | -11.38 | -11.38 |
| EBIT | - 146.91 | -29.33 | 107.28 | -21.68 | -31.87 |
| Pre-tax profit | - 146.91 | -29.33 | 107.28 | -21.68 | -31.87 |
| Net earnings | - 146.91 | -29.33 | 107.28 | -21.68 | -31.87 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible rights | 99.04 | 87.66 | 76.29 | 64.91 | 53.53 |
| Intangible assets total | 99.04 | 87.66 | 76.29 | 64.91 | 53.53 |
| Tangible assets total | |||||
| Participating interests | 12.50 | ||||
| Investments total | 12.50 | ||||
| Non-current loans receivable | 12.50 | 12.50 | 12.50 | 12.50 | |
| Long term receivables total | 12.50 | 12.50 | 12.50 | 12.50 | |
| Inventories total | |||||
| Current other receivables | 1.41 | 12.26 | 0.26 | ||
| Short term receivables total | 1.41 | 12.26 | 0.26 | ||
| Cash and bank deposits | 36.56 | 8.33 | 182.57 | 128.42 | 110.34 |
| Cash and cash equivalents | 36.56 | 8.33 | 182.57 | 128.42 | 110.34 |
| Balance sheet total (assets) | 149.52 | 120.75 | 271.36 | 206.09 | 176.36 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 260.00 | 260.00 | 260.00 | 260.00 | 260.00 |
| Retained earnings | 25.73 | - 121.18 | - 150.51 | -43.23 | -64.91 |
| Profit of the financial year | - 146.91 | -29.33 | 107.28 | -21.68 | -31.87 |
| Shareholders equity total | 138.82 | 109.49 | 216.77 | 195.09 | 163.22 |
| Non-current liabilities total | |||||
| Current trade creditors | 10.70 | 11.26 | 20.54 | 11.00 | 11.50 |
| Other non-interest bearing current liabilities | 34.05 | 1.64 | |||
| Current liabilities total | 10.70 | 11.26 | 54.59 | 11.00 | 13.14 |
| Balance sheet total (liabilities) | 149.52 | 120.75 | 271.36 | 206.09 | 176.36 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated